The involvement of the central nervous system in the disease in our patients was indicated by clinical signs and symptoms including global developmental delay, psychomotor deterioration, seizures, brain MRI alterations and increased levels of the CSF markers NFL and GFAP suggestive of neuroaxonal and astroglial injury. The gene discussed is NEFL; the disease is Global developmental delay.